These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 17729182)

  • 21. Analysis of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes.
    Coppola G; Corrado E; Mulè MC; Augugliaro S; Cucchiara A; Novo G; Amoroso G; Assennato P; Hoffmann E; Vitale F; Novo S
    Coron Artery Dis; 2009 May; 20(3):225-9. PubMed ID: 19387249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laboratory diagnosis of acute myocardial injury.
    Melanson SF; Tanasijevic MJ
    Cardiovasc Pathol; 2005; 14(3):156-61. PubMed ID: 15914301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The value of bedside cardiac multibiomarker assay in rapid and accurate diagnosis of acute coronary syndromes.
    Dadkhah S; Sharain K; Sharain R; Kiabayan H; Foschi A; Zonia C; Huettl B; French S; Gray E; Venkatachalam S; Hegazy H; Aldinger G
    Crit Pathw Cardiol; 2007 Jun; 6(2):76-84. PubMed ID: 17667870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combining natriuretic peptides and necrosis markers in the assessment of acute coronary syndromes.
    de Lemos JA; Morrow DA
    Rev Cardiovasc Med; 2003; 4 Suppl 4():S37-46. PubMed ID: 14564227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Markers for early detection of cardiac diseases.
    Wu AH
    Scand J Clin Lab Invest Suppl; 2005; 240():112-21. PubMed ID: 16112968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac troponins--biochemical markers of cardiac toxicity after cytostatic therapy.
    Urbanová D; Urban L; Carter A; Maasova D; Mladosievicova B
    Neoplasma; 2006; 53(3):183-90. PubMed ID: 16652186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biomarkers in acute coronary syndrome and percutaneous coronary intervention.
    Searle J; Danne O; Müller C; Mockel M
    Minerva Cardioangiol; 2011 Jun; 59(3):203-23. PubMed ID: 21516070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac biomarkers in neonatal hypoxic ischaemia.
    Sweetman D; Armstrong K; Murphy JF; Molloy EJ
    Acta Paediatr; 2012 Apr; 101(4):338-43. PubMed ID: 22118561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Usefulness of rapid bedside assay of cardiac troponin I and creatine phosphokinase-MB in acute ischemic coronary syndromes].
    Meraz Soria CA; Camarena Alejo G; Elizalde González JJ; Aguirre Sánchez J; Martínez Sánchez J
    Arch Cardiol Mex; 2006; 76(1):37-46. PubMed ID: 16749500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Biochemical markers in acute coronary syndrome].
    Romić Z; Mayer L; Kirin M
    Acta Med Croatica; 2004; 58(2):111-4. PubMed ID: 15208794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exercise-associated increases in cardiac biomarkers.
    Scharhag J; George K; Shave R; Urhausen A; Kindermann W
    Med Sci Sports Exerc; 2008 Aug; 40(8):1408-15. PubMed ID: 18614952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical and hemodynamic factors that influence the concentrations of biomarkers of myocyte injury measured by high sensitive assay PATHFAST.
    Sato Y; Miyamoto T; Taniguchi R; Nagao K; Matsuoka T; Fukuhara R; Kuwabara Y; Isoda K; Yamane K; Nishi K; Saijyo S; Fujiwara H; Takatsu Y
    J Cardiol; 2009 Feb; 53(1):20-7. PubMed ID: 19167634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B-type natriuretic peptide signal peptide circulates in human blood: evaluation as a potential biomarker of cardiac ischemia.
    Siriwardena M; Kleffmann T; Ruygrok P; Cameron VA; Yandle TG; Nicholls MG; Richards AM; Pemberton CJ
    Circulation; 2010 Jul; 122(3):255-64. PubMed ID: 20606123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response Biomedical releases positive preclinical results of RAMP cardiac marker tests.
    Expert Rev Mol Diagn; 2003 Jan; 3(1):6-7. PubMed ID: 12528358
    [No Abstract]   [Full Text] [Related]  

  • 35. Use of cardiac biomarkers in neonatology.
    Vijlbrief DC; Benders MJ; Kemperman H; van Bel F; de Vries WB
    Pediatr Res; 2012 Oct; 72(4):337-43. PubMed ID: 22797141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pregnancy associated plasma protein a as a quick and sensitive biomarker in early phase of acute coronary syndrome.
    Hajek P; Macek M
    Am J Cardiol; 2008 Oct; 102(7):954. PubMed ID: 18805129
    [No Abstract]   [Full Text] [Related]  

  • 37. Cardiac troponin monitoring for detection of myocardial infarction: newer generation assays are here to stay.
    Apple FS
    Clin Chim Acta; 2007 May; 380(1-2):1-3; discussion 245-6. PubMed ID: 17306782
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of biomarkers in the emergency department and chest pain unit.
    Jaffe AS
    Cardiol Clin; 2005 Nov; 23(4):453-65, vi. PubMed ID: 16278117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of ischemia-modified albumin in estimating the extent and scope of cardiac ischemia in patients with ST elevation myocardial infarction.
    Chek J; Dusek J; Stasek J; Vojacek J; Bis J; Ulrychova M; Tichy M; Tomko T; Bukac J
    Heart Vessels; 2011 Nov; 26(6):622-7. PubMed ID: 21267579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biomarkers of vulnerable plaque: the missing link with ischemia.
    Muller O; Barbato E; De Bruyne B; Bartunek J
    Biomark Med; 2010 Jun; 4(3):375-83. PubMed ID: 20550471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.